Clinical trial of trimethoprim-sulfamethoxazole in the treatment of vivax, ovale and falciparum malaria.
スポンサーリンク
概要
- 論文の詳細を見る
A compound of trimethoprim (TMP) and sulfamethoxazole (SMZ) was effective in the treatment of vivax, ovale and falciparum malaria. Two patients with vivax malaria received 16 mg TMP /80 mg SMZ /kg body weight in 3 divided doses daily for 3 days. A patient with ovale malaria received 10 mg TMP /50 mg SMZ /kg body weight in 4 divided doses daily for 4 days. These doses were followed by 15 mg primaquine daily for 2 weeks. A patient with falciparum malaria received 16 mg TMP /80 mg SMZ /kg body weight in 3 divided doses daily for 3 days. In all patients, radical cures were achieved; neither relapse nor recrudescence has occurred. Trimethoprim-sulfamethoxazole succeeded in causing rapid clearance of asexualparasites from peripheral blood of the patients and producing rapid defervescence. No symptomatic adverse reactions to TMP-SMZ were experienced.
- 日本熱帯医学会の論文
日本熱帯医学会 | 論文
- マレーシア産ウエステルマン肺吸虫の動物体内での発育と動物間における伝播
- わが国における輸入マラリアの現況
- 家兎アカントアメーバ角膜炎の臨床像および組織所見
- 長崎市の犬糸状虫の伝搬における飼い犬の室内飼育の影響
- ミトコンドリア12S rRNA遺伝子領域から推測した,Oncomelania属及びTricula属の系統類縁関係